AstraZeneca Adds Intellipharmaceutics To Seroquel Row
AstraZeneca Pharmaceuticals LP hit Intellipharmaceutics Corp. with a suit Monday in New Jersey federal court, adding the company to the list of generic-drug makers accused of infringing a patent for schizophrenia...To view the full article, register now.
Already a subscriber? Click here to view full article